Fulbright Scholar Fellowships are esteemed fellowships that involve a rigorous application process and provide a unique opportunity for scholars to teach or conduct research overseas. Past recipients include numerous Nobel Prize winners, Pulitzer Prize winners, MacArthur Fellows and other world-renowned experts. The program benefits the individual recipient by promoting cross-cultural communication skills and opening doors to greater international co-publication. With this award, Palaniappan will also strengthen Stanford University’s relationships with scholars, prospective students, and alumni around the world.
Palaniappan is an internist and clinician researcher who focuses on the study of diverse populations, chronic disease, and prevention. She piloted the first pharmacogenomics clinic at Stanford University and serves on the editorial board of Journal of Personalized Medicine.
The Fulbright Award builds on Palaniappan’s previous accomplishments in supporting his interest in implementing pharmacogenomics in healthcare systems around the world. In Australia, it will join the Commonwealth Scientific and Industrial Research Organization (CSIRO) explore pharmacogenomic testing in a universal health care system. This effort, she says, is crucial to strengthening global health. “Integrating precision health into our daily clinical interactions is critical to improving health outcomes for all populations,” she explains.
We wish her the best as she travels overseas on her mission to advance precision medicine!